(Press-News.org) SAN DIEGO – Apparent stem cell transplant success in mice may hold promise for people with amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease. The results of the study were released today and will be presented at the American Academy of Neurology's 65th Annual Meeting in San Diego, March 16 to 23, 2013.
"There have been remarkable strides in stem cell transplantation when it comes to other diseases, such as cancer and heart failure," said study author Stefania Corti, MD, PhD, with the University of Milan in Italy and a member of the American Academy of Neurology. "ALS is a fatal, progressive, degenerative disease that currently has no cure. Stem cell transplants may represent a promising avenue for effective cell-based treatment for ALS and other neurodegenerative diseases."
For the study, mice with an animal model of ALS were injected with human neural stem cells taken from human induced pluripotent stem cells (iPSCs). iPSC are adult cells such as skin cells that have been genetically reprogrammed to an embryonic stem cell-like state. Neurons are a basic building block of the nervous system, which is affected by ALS. After injection, the stem cells migrated to the spinal cord of the mice, matured and multiplied.
The study found that stem cell transplantation significantly extended the lifespan of the mice by 20 days and improved their neuromuscular function by 15 percent.
"Our study shows promise for testing stem cell transplantation in human clinical trials," said Corti.
INFORMATION:
The study was supported by AriSLA - The Italian Foundation for Research on Amyotrophic Lateral Sclerosis (ALS).
Learn more about ALS at http://www.aan.com/patients.
The American Academy of Neurology, an association of more than 25,000 neurologists and neuroscience professionals, is dedicated to promoting the highest quality patient-centered neurologic care. A neurologist is a doctor with specialized training in diagnosing, treating and managing disorders of the brain and nervous system such as Alzheimer's disease, stroke, migraine, multiple sclerosis, brain injury, Parkinson's disease and epilepsy.
For more information about the American Academy of Neurology, visit http://www.aan.com or find us on Facebook, Twitter, Google+ and YouTube.
Media Contacts:
Rachel Seroka, , (612) 928-6129
Angela Babb, APR, ababb@aan.com, (612) 928-6102
END
VIDEO:
This is a video clip of a bamboo shark embryo responding to an electrical stimulus by ceasing gill movements.
Click here for more information.
Baby sharks still developing in their egg cases can sense when predators are near, and keep very still to avoid being detected, according to research published January 9 in the open access journal PLOS ONE by Ryan Kempster from the University of Western Australia and colleagues.
Adult sharks are known to use highly sensitive ...
You may have to be over a certain age to be a contestant on "Deal or No Deal", but children as young as five start to maximize their profits - in cookies - when making decisions similar to those on the show, according to research published January 9 in the open access journal PLOS ONE by Valerie Dufour and colleagues from the National Center for Scientific Research in France.
Children aged 3-9 were given a cookie and presented the option to either keep it or exchange it for one of 6 identical cups containing cookies. The cookies in the cups could be larger, smaller or ...
VIDEO:
This is an intravital microscopy of the skin window of tumors in mice injected with
SSRBCs or NLRBCs.
Click here for more information.
The genetic mutation that causes sickle cell anemia also turns red blood cells into potent tumor killers and may offer a new way to treat some cancers that are resistant to existing treatments, according to research published January 9 in the open access journal PLOS ONE by David S. Terman of Jenomic Research Institute and colleagues ...
People view brown-eyed faces as more trustworthy than those with blue eyes, except if the blue eyes belong to a broad-faced man, according to research published January 9 in the open access journal PLOS ONE by Karel Kleisner and colleagues from Charles University in the Czech Republic.
The study's results attempt to answer a larger question: What makes us think a person's face looks trustworthy? The authors asked study participants to rate male and female faces for trustworthiness based on two features: eye color and face shape. A significant number of participants found ...
DURHAM, N.C. – By harnessing the very qualities that make sickle cell disease a lethal blood disorder, a research team led by Duke Medicine and Jenomic, a private cancer research company in Carmel, Calif., has developed a way to deploy the misshapen red blood cells to fight cancer tumors.
Reporting in the Jan. 9, 2013, edition of the on-line journal, PLOS ONE, the researchers describe a process of exploiting sickle-shaped red blood cells to selectively target oxygen deprived cancer tumors in mice and block the blood vessels that surround them.
"Sickle cells appear ...
Using cervical fluid obtained during routine Pap tests, scientists at the Johns Hopkins Kimmel Cancer Center have developed a test to detect ovarian and endometrial cancers. In a pilot study, the "PapGene" test, which relies on genomic sequencing of cancer-specific mutations, accurately detected all 24 (100 percent) endometrial cancers and nine of 22 (41 percent) ovarian cancers. Results of the experiments are published in the January 9 issue of the journal, Science Translational Medicine.
The investigators note that larger scale studies are needed before clinical implementation ...
Astronomers have discovered hundreds of previously-unknown sites of massive star formation in the Milky Way, including the most distant such objects yet found in our home Galaxy. Ongoing studies of these objects promise to give crucial clues about the structure and history of the Milky Way.
The scientists found regions where massive young stars or clusters of such stars are forming. These regions, which astronomers call HII (H-two) regions, serve as markers of the Galaxy's structure, including its spiral arms and central bar.
"We're vastly improving the census of our ...
A team of scientists has developed a playbook for ending the devastating impact of fibrotic diseases of the liver, lung, kidney, and other organs, which are responsible for as many as 45 percent of all deaths in the industrialized world. Despite the prevalence of these illnesses, which are caused by buildup of scar tissue, there are no approved antifibrotic drugs on the market in the U.S. A top fibrosis expert from the Icahn School of Medicine at Mount Sinai and three other institutions have described drug targets and compounds they hope will prove broadly effective in ...
Researchers in California and Switzerland have discovered that melanomas that develop resistance to the anti-cancer drug vemurafenib (marketed as Zelboraf), also develop addiction to the drug, an observation that may have important implications for the lives of patients with late-stage disease.
The team, based at the University of California, San Francisco (UCSF), the Novartis Institutes for Biomedical Research (NIBR) in Emeryville, Calif., and University Hospital Zurich, found that one mechanism by which melanoma cells become resistant to vemurafenib also renders them ...
What if you had a "Wayback Television Set" and could watch an entire month of ancient prehistory unfold before your eyes in real time? David Rubin of the U.S. Department of Energy's Lawrence Berkeley National Laboratory (Berkeley Lab) presented just such a scenario to the American Astronomical Society (AAS) meeting in Long Beach, CA, when he announced the discovery of a striking astronomical object: a Type Ia supernova with a redshift of 1.71 that dates back 10 billion years in time. Labeled SN SCP-0401, the supernova is exceptional for its detailed spectrum and precision ...
